User profiles for "author:Jacques Morel"
Jacques MorelCHRU et Université de Montpellier Verified email at chu-montpellier.fr Cited by 13087 |
Effect of methotrexate, anti–tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid …
C Hua, T Barnetche, B Combe… - Arthritis care & research, 2014 - Wiley Online Library
Objective To assess the current literature on the impact of rheumatoid arthritis (RA)
treatments on the humoral response to pneumococcal and influenza vaccines. Methods We …
treatments on the humoral response to pneumococcal and influenza vaccines. Methods We …
Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases
CI Daïen, A Monnier, P Claudepierre… - …, 2009 - academic.oup.com
Objective. TNF blockers have been recently evaluated for treating refractory sarcoidosis and
could be efficient. However, several cases of sarcoidosis have been diagnosed during anti …
could be efficient. However, several cases of sarcoidosis have been diagnosed during anti …
Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis
C Rempenault, B Combe, T Barnetche… - Annals of the …, 2018 - ard.bmj.com
Objective Cardiovascular disease (CVD) is the leading cause of mortality in patients with
rheumatoid arthritis (RA). Hydroxychloroquine (HCQ) has been shown to improve survival …
rheumatoid arthritis (RA). Hydroxychloroquine (HCQ) has been shown to improve survival …
Treatment of primary Sjögren syndrome with rituximab: a randomized trial
V Devauchelle-Pensec, X Mariette… - Annals of internal …, 2014 - acpjournals.org
Background: Primary Sjögren syndrome (pSS) is an autoimmune disorder characterized by
ocular and oral dryness or systemic manifestations. Objective: To evaluate efficacy and …
ocular and oral dryness or systemic manifestations. Objective: To evaluate efficacy and …
Routine analyses of trace elements in geological samples using flow injection and low pressure on‐line liquid chromatography coupled to ICP‐MS: A study of …
J Carignan, P Hild, G Mevelle, J Morel… - Geostandards …, 2001 - Wiley Online Library
We describe analytical procedures for trace element determinations developed at the CNRS
Service d'Analyse des Roches et des Minéraux (SARM) and report results obtained for five …
Service d'Analyse des Roches et des Minéraux (SARM) and report results obtained for five …
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial
JE Gottenberg, P Ravaud, X Puéchal, V Le Guern… - Jama, 2014 - jamanetwork.com
Importance Primary Sjögren syndrome is a systemic autoimmune disease characterized by
mouth and eye dryness, pain, and fatigue. Hydroxychloroquine is the most frequently …
mouth and eye dryness, pain, and fatigue. Hydroxychloroquine is the most frequently …
Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant‐induced arthritis
JH Ruth, MV Volin, GK Haines III… - … : Official Journal of …, 2001 - Wiley Online Library
Objective To examine the expression of the novel CX3C chemokine fractalkine (Fkn) and its
receptor (CX3CR1) in rheumatoid arthritis (RA) and rat adjuvant‐induced arthritis (AIA), a …
receptor (CX3CR1) in rheumatoid arthritis (RA) and rat adjuvant‐induced arthritis (AIA), a …
Evidence of IL-18 as a novel angiogenic mediator
CC Park, J Morel, MA Amin, MA Connors… - The Journal of …, 2001 - journals.aai.org
Angiogenesis, or new blood vessel growth, is a key process in the development of synovial
inflammation in rheumatoid arthritis (RA). Integral to this pathologic proliferation are …
inflammation in rheumatoid arthritis (RA). Integral to this pathologic proliferation are …
[HTML][HTML] Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome …
JE Gottenberg, R Seror, C Miceli-Richard… - PloS one, 2013 - journals.plos.org
Objectives To analyze the clinical and immunological characteristics at enrollment in a large
prospective cohort of patients with primary Sjögren's syndrome (pSS) and to investigate the …
prospective cohort of patients with primary Sjögren's syndrome (pSS) and to investigate the …
Non–TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical …
JE Gottenberg, O Brocq, A Perdriger, S Lassoued… - Jama, 2016 - jamanetwork.com
Importance One-third of patients with rheumatoid arthritis show inadequate response to
tumor necrosis factor α (TNF-α) inhibitors; little guidance on choosing the next treatment …
tumor necrosis factor α (TNF-α) inhibitors; little guidance on choosing the next treatment …